Targeting Breast Cancer: Advances in Multimodal Imaging and Oncoplastic Breast Surgery

Dear Colleagues,

Breast cancer is still the major cause of mortality of women in Europe and Western countries. However, according to recent data, the rates of mortality are declining, with the falls being largest in the age group covered by mammography screening and also in the age group from 20 to 49 years. Advances in imaging performed with multimodal techniques are essential for earlier diagnosis and treatment and, thus, improvement of survival rates with primary breast cancer. To preserve the shape and function of the breast, surgery has developed towards minimally invasive procedures with oncoplastic techniques. It is vital for optimal results that the extent of the tumor is visualized precisely before, during, and after surgery with appropriate imaging techniques, enhancing the rate of margin-free specimens and reducing the need for re-operations. Thus, breast cancer surgery guided by multimodal imaging may be as targeted as systemic therapy targets different tumor profiles.

Especially after exposure of the tumor to cytotoxic drugs with neoadjuvant chemotherapy, it is a challenge to measure the exact size of residual tumor burden and to determine the resection lines.

Complementary diagnostic tools are now evolving, including mammography, tomosynthesis, high-resolution B-mode breast ultrasound, three-dimensional breast ultrasound, strain elastography, shear elastography, automated breast volume scan (ABVS), contrast-enhanced ultrasound (CEUS), MRI, PET-MRI, and MRI-navigated ultrasound.

This issue on “Advances in Multimodal Imaging and Oncoplastic Breast Surgery” encourages scientists to publish their groundbreaking work on advances in imaging and surgical treatment of the main cancer entity of women.

Dr. Peter Kern
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• breast cancer
• targeted breast surgery
• breast ultrasound
• ultrasound-guided breast surgery
• multimodal imaging
• magnetic resonance imaging
• MRI-navigated ultra-sound
• mammography
• tomosynthesis
• three-dimensional imaging
• ultra-staging
• contrast-enhanced ultrasound
• automated breast volume scan
• shear wave elastography
• strain elastography
• hybrid imaging